In contrast, the mutations significantly reduced the receptor activity when EX4-fused ECD was expressed separately from the TMD, especially for the Q211A/H212A/Q213A, E373A/H374A/A375 and V370A/M371A/D372A mutations, which nearly abolished the receptor activity (Figure 8a and e, expression levels shown in Supplementary Figure S2B and D and the normalized activity shown in Supplementary Figure S3A and C)
FDA identified particular concern for proposed injectable exposure because no clinical immunogenicity or aggregation studies were available
Sound too good to be true
Khatoon S, Kalam N (2025) Mechanistic insight of curcumin: a potential pharmacological candidate for epilepsy
Moreover, a heterozygotic loss of Cpt2 has been previously shown to delay the postnatal cell cycle withdrawal of mouse cardiomyocytes 36 , supporting the role of the fat-rich diet and fatty-acid metabolism in limiting cardiomyocyte proliferation and regeneration